All Resources

Access to Medicine • October 19, 2023

Cost Drivers Report 2023

Learn more | View

June 08, 2023

Submission for the parliamentary consultations on Bill 15—An Act to Make the Health and Social Services more effective

Learn more | View

Pharmacare • June 01, 2023

Addendum to Innovative Medicines Canada Submission on National Pharmacare

Learn more | View

Access to Medicine • May 16, 2023

Developing a Canadian managed entry approach for new innovation: What can Canada learn from Europe?

Learn more | View

Access to Medicine • February 15, 2023

Increasing Access to Innovative Medicines

The impact of the COVID-19 pandemic has shifted the health landscape in Canada. While the federal government has demonstrated its ability to react to an unprecedented health crisis, doing so…

Learn more | View

Access to Medicine • February 15, 2023

Alberta Budget Submission 2023

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • December 05, 2022

The Suspension and Reformulation of the PMPRB Guidelines is Urgently Required: IMC Response to PMPRB 2022 Guidelines Proposals

Learn more | View

Private Drug Coverage • November 25, 2022

Cost Drivers: Analysis of Private Drug Plans in Canada 2022

Learn more | View

Access to Medicine • November 17, 2022

Innovative Agreements Framework

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • November 09, 2022

Letter to The Honourable Jean-Yves Duclos, P.C., M.P.

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • November 09, 2022

Letter to The Hon. Chrystia Freeland, P.C., M.P.

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • November 09, 2022

Letter to The Honourable Mary Ng, P.C., M.P.

Learn more | View